- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00000902
A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment
RAD-1: A Phase I/II Antiretroviral Management Algorithm for Pediatric Subjects of Four-Drug Combination Therapies Based on Prior Antiretroviral Experience
The purpose of this study is to determine the value of changing anti-HIV medications in children with progressive HIV disease who have received previous treatment.
Plasma viral load (the level of HIV in the blood) is probably most effectively reduced by giving patients anti-HIV drugs which affect the virus at various stages of development. Changing the medications may enhance the results of treatment.
Study Overview
Status
Conditions
Detailed Description
The Master RAD Protocol is based on the concept that optimal suppression of viral load in vivo will be achieved in patients with rapidly progressing or advanced HIV disease (RAD) using antiretroviral combinations inhibiting viral replication at distinct sites of action. Antiretroviral combinations are chosen with the hypothesis that simultaneous change to as many new agents as possible is necessary to maximally reduce plasma viral load.
In this open-label, multicenter study patients are randomized into 1 of 4 groups based on prior antiretroviral experience. Each regimen consists of 4 drugs that include a combination of nucleoside reverse transcriptase inhibitors (stavudine, lamivudine, zidovudine, didanosine, zalcitabine) plus nevirapine (NVP), nelfinavir (NFV), or ritonavir (RTV). Patients must be naive to at least 2 of the 4 drugs in the regimen and at least 1 of the novel drugs must be NVP, NFV, or RTV.
Prior to randomization to a NFV- or RTV-containing regimen, patients are stratified by HIV RNA (greater than or equal to 50,000 or less than 50,000) and must able to receive 2 or more novel drugs.
Study Type
Enrollment
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Bayamon, Puerto Rico, 00956
- Ramon Ruiz Arnau Univ Hosp / Pediatrics
-
San Juan, Puerto Rico, 009367344
- San Juan City Hosp
-
San Juan, Puerto Rico, 009365067
- Univ of Puerto Rico / Univ Children's Hosp AIDS
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- Univ of Alabama at Birmingham - Pediatric
-
Mobile, Alabama, United States, 36604
- Univ of South Alabama
-
-
California
-
La Jolla, California, United States, 920930672
- UCSD Med Ctr / Pediatrics / Clinical Sciences
-
Long Beach, California, United States, 90801
- Long Beach Memorial (Pediatric)
-
Los Angeles, California, United States, 90033
- Los Angeles County - USC Med Ctr
-
Los Angeles, California, United States, 900481804
- Cedars Sinai / UCLA Med Ctr
-
Los Angeles, California, United States, 905022004
- Harbor - UCLA Med Ctr / UCLA School of Medicine
-
Oakland, California, United States, 946091809
- Children's Hosp of Oakland
-
San Francisco, California, United States, 941430105
- UCSF / Moffitt Hosp - Pediatric
-
-
Colorado
-
Denver, Colorado, United States, 802181088
- Children's Hosp of Denver
-
-
Connecticut
-
Farmington, Connecticut, United States, 060303805
- Connecticut Children's Med Ctr
-
New Haven, Connecticut, United States, 06504
- Yale Univ Med School
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20060
- Howard Univ Hosp
-
-
Florida
-
Fort Lauderdale, Florida, United States, 33311
- North Broward Hosp District
-
Jacksonville, Florida, United States, 32209
- Univ of Florida Health Science Ctr / Pediatrics
-
Miami, Florida, United States, 33161
- Univ of Miami (Pediatric)
-
-
Georgia
-
Atlanta, Georgia, United States, 30306
- Emory Univ Hosp / Pediatrics
-
Augusta, Georgia, United States, 30912
- Med College of Georgia
-
Columbus, Georgia, United States, 31901
- The Med Ctr Inc
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Cook County Hosp
-
Chicago, Illinois, United States, 606143394
- Chicago Children's Memorial Hosp
-
Chicago, Illinois, United States, 60612
- Univ of Illinois College of Medicine / Pediatrics
-
-
Louisiana
-
New Orleans, Louisiana, United States, 701122699
- Tulane Univ / Charity Hosp of New Orleans
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Univ of Maryland at Baltimore / Univ Med Ctr
-
Baltimore, Maryland, United States, 212874933
- Johns Hopkins Hosp - Pediatric
-
-
Massachusetts
-
Boston, Massachusetts, United States, 021155724
- Children's Hosp of Boston
-
Boston, Massachusetts, United States, 02118
- Boston City Hosp / Pediatrics
-
Springfield, Massachusetts, United States, 01199
- Baystate Med Ctr of Springfield
-
Worcester, Massachusetts, United States, 016550001
- Univ of Massachusetts Med School
-
-
Mississippi
-
Jackson, Mississippi, United States, 39213
- Univ of Mississippi Med Ctr
-
-
New Jersey
-
New Brunswick, New Jersey, United States, 089030019
- UMDNJ - Robert Wood Johnson Med School / Pediatrics
-
Newark, New Jersey, United States, 071032714
- Univ of Medicine & Dentistry of New Jersey / Univ Hosp
-
Newark, New Jersey, United States, 07103
- Saint Joseph's Hosp and Med Ctr/UMDNJ - New Jersey Med Schl
-
-
New York
-
Albany, New York, United States, 12208
- Children's Hosp at Albany Med Ctr
-
Bronx, New York, United States, 10457
- Bronx Lebanon Hosp Ctr
-
Brooklyn, New York, United States, 11203
- SUNY - Brooklyn
-
Great Neck, New York, United States, 11021
- North Shore Univ Hosp
-
New Hyde Park, New York, United States, 11040
- Schneider Children's Hosp
-
New York, New York, United States, 10016
- Bellevue Hosp / New York Univ Med Ctr
-
New York, New York, United States, 10029
- Metropolitan Hosp Ctr
-
New York, New York, United States, 10021
- Cornell Univ Med College
-
New York, New York, United States, 10032
- Columbia Presbyterian Med Ctr
-
New York, New York, United States, 10032
- Incarnation Children's Ctr / Columbia Presbyterian Med Ctr
-
New York, New York, United States, 10037
- Harlem Hosp Ctr
-
Rochester, New York, United States, 146420001
- Univ of Rochester Med Ctr
-
Stony Brook, New York, United States, 117948111
- State Univ of New York at Stony Brook
-
Syracuse, New York, United States, 13210
- SUNY Health Sciences Ctr at Syracuse / Pediatrics
-
-
North Carolina
-
Durham, North Carolina, United States, 277103499
- Duke Univ Med Ctr
-
Durham, North Carolina, United States, 27710
- Univ of North Carolina at Chapel Hill / Duke Univ Med Ctr
-
-
Ohio
-
Columbus, Ohio, United States, 432052696
- Columbus Children's Hosp
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 191044318
- Children's Hosp of Philadelphia
-
Philadelphia, Pennsylvania, United States, 191341095
- Saint Christopher's Hosp for Children
-
-
South Carolina
-
Charleston, South Carolina, United States, 294253312
- Med Univ of South Carolina
-
-
Tennessee
-
Memphis, Tennessee, United States, 381052794
- Saint Jude Children's Research Hosp of Memphis
-
Nashville, Tennessee, United States, 372322581
- Vanderbilt Univ Med Ctr
-
-
Texas
-
Dallas, Texas, United States, 75235
- Children's Med Ctr of Dallas
-
Houston, Texas, United States, 77030
- Texas Children's Hosp / Baylor Univ
-
-
Virginia
-
Norfolk, Virginia, United States, 23507
- Children's Hosp of the King's Daughters
-
Richmond, Virginia, United States, 23219
- Med College of Virginia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
Your child may be eligible for this study if he or she:
- Is HIV-positive.
- Is between the ages of 6 months and 21 years (consent of parent or guardian required if under 18).
- Has an HIV blood level above 50,000 copies/mL on 2 consecutive occasions, while taking anti-HIV therapy.
- Has advanced HIV disease or disease progression while receiving 8 weeks or more of continuous unchanged anti-HIV therapy.
- Is able to receive at least one of the following: RTV, NVP, or NFV.
Exclusion Criteria
Your child will not be eligible for this study if he or she:
- Is receiving treatment for a serious bacterial, viral, or opportunistic (HIV-associated) infection within 14 days prior to study entry.
- Has a history of pancreatitis or peripheral neuropathy.
- Has cancer requiring chemotherapy.
- Is allergic to the study medications.
- Is taking certain medications.
- Is pregnant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
Collaborators and Investigators
Investigators
- Study Chair: Sandra Burchett
- Study Chair: Andrea Kovacs
Publications and helpful links
General Publications
- Saitoh A, Sarles E, Capparelli E, Aweeka F, Kovacs A, Burchett SK, Wiznia A, Nachman S, Fenton T, Spector SA. CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children. AIDS. 2007 Oct 18;21(16):2191-9. doi: 10.1097/QAD.0b013e3282ef9695.
- Weinberg A, Pahwa S, Oyomopito R, Carey VJ, Zimmer B, Mofenson L, Kovacs A, Burchett SK; Pediatric AIDS Clinical Trials Group 366 Team. Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2004 Jul 1;39(1):107-14. doi: 10.1086/420931. Epub 2004 Jun 14.
- Weinberg A, Kovacs A, Pahwa S, Carey V, Oyomopito R, Mofenson L, Khoury M, Zimmer B, Burchett S. HIV-infected children on HAART reconstitute tetanus-specific T cell responses without booster vaccination. 8th Conf Retro and Opportun Infect. 2001 Feb 4-8 (abstract no 688)
- Frenkel LM, Burchett SK, Aldrovandi GM, Carey V, Oyomopito R, Mahalanibis M, Decker D, Kovacs A. HIV-1 reverse transcriptase (RT) M184V/I improves the rate of suppression of viral replication by salvage therapy. 8th Conf Retro and Opportun Infect. 2001 Feb 4-8 (abstract no 463)
- Kovacs A, Burchett S, Khoury M, Carey V, Pahwa S, McIntosh K, Oyomopito R, Smith E, Mofenson L. Virologic and immunologic responses in children with advanced HIV disease on a new HAART regimen (PACTG 366). 8th Conf Retro and Opportun Infect. 2001 Feb 4-8 (abstract no 684)
- EV Capparelli, SK Burchett, A Kovacs, M Khoury, R Oyomopito, L Mofenson, B Zimmer, D Holland. Characterization of the Ritonavir-Nelfinavir Pharmacokinetic Interaction in Pediatric Patients with Advanced HIV Disease Using a Mixed Effects Modeling Approach, Pharmacotherapy, (2003), Abstract 67, Vol.23, No.3, pp.401.
- S. Burchett, M. Khoury, K. McIntosh, V. Carey, R. Oyomopito, L. Mofenson, E. Smith, A. Kovacs, Viral Load Reduction in Children with Advanced HIV Disease Treated with 4-Drug Antiretroviral Treatment Regimens Including NRTIs, Nevirapine, Nelfinavir and/or Ritonavir, CROI, 2000.
Study record dates
Study Major Dates
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- HIV Infections
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Antiviral Agents
- Reverse Transcriptase Inhibitors
- Nucleic Acid Synthesis Inhibitors
- Enzyme Inhibitors
- Anti-HIV Agents
- Anti-Retroviral Agents
- Antimetabolites
- Protease Inhibitors
- Cytochrome P-450 CYP3A Inhibitors
- Cytochrome P-450 Enzyme Inhibitors
- Cytochrome P-450 Enzyme Inducers
- Cytochrome P-450 CYP3A Inducers
- HIV Protease Inhibitors
- Viral Protease Inhibitors
- Nevirapine
- Ritonavir
- Lamivudine
- Zidovudine
- Stavudine
- Didanosine
- Nelfinavir
- Zalcitabine
Other Study ID Numbers
- ACTG 366
- 11329 (Registry Identifier: DAIDS ES)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on Nevirapine
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Botswana, Germany, South Africa
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, France, Germany, United Kingdom
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Argentina, Australia, Belgium, Botswana, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Portugal, Puerto Rico, Romania, Russian Federation, South Africa, Spain, Switzerland, United Kingdom
-
Boehringer IngelheimCompleted
-
Peking Union Medical CollegeMinistry of Science and Technology of the People´s Republic of ChinaCompleted
-
Boehringer IngelheimCompleted
-
Makerere UniversityUniversity of LiverpoolCompletedHIV Infections | TuberculosisUganda
-
Boehringer IngelheimCompletedHIV InfectionsArgentina, Germany, Italy, Mexico, Poland, Portugal, Romania, Spain, Switzerland, United Kingdom
-
Elim Pediatric Pharmaceuticals Inc.Unknown